HUSSMAN STRATEGIC ADVISORS, INC.

Position in GILD — Gilead Sciences, Inc.

CIK 1179475 ELLICOTT CITY, MD

Position in GILD

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$1,463,385

-$340,893 QoQ

Shares Held

10,500

-28.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HUSSMAN STRATEGIC ADVISORS, INC. holds $8,590,428 across 3 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	BIIB	Biogen Inc.	21,000	$4,537,260
2	AMGN	Amgen Inc	8,400	$3,041,808
3	PFE	Pfizer Inc	42,000	$1,011,360

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,463,385	10,500	-28.6%	Shares	Sole	2026-05-11
2025-12-31	$1,804,278	14,700	-30.0%	Shares	Sole	2026-02-02
2025-09-30	$2,331,000	21,000	0.0%	Shares	Sole	2025-11-03
2025-06-30	$2,328,270	21,000	-50.0%	Shares	Sole	2025-08-05
2024-06-30	$2,881,620	42,000	0.0%	Shares	Sole	2024-08-01
2024-03-31	$3,076,500	42,000	0.0%	Shares	Sole	2024-05-01
2023-12-31	$3,402,420	42,000	0.0%	Shares	Sole	2024-02-01
2023-09-30	$3,147,480	42,000	+11.7%	Shares	Sole	2023-11-08
2023-06-30	$2,897,832	37,600	+51.6%	Shares	Sole	2023-08-03
2023-03-31	$2,057,656	24,800	0.0%	Shares	Sole	2023-05-05
2022-12-31	$2,129,080	24,800	-20.5%	Shares	Sole	2023-02-08
2022-09-30	$1,924,728	31,200	0.0%	Shares	Sole	2022-11-02
2022-06-30	$1,928,472	31,200	0.0%	Shares	Sole	2022-09-12
2022-03-31	$1,854,840	31,200	0.0%	Shares	Sole	2022-05-04
2021-12-31	$2,265,432	31,200	+52.9%	Shares	Sole	2022-01-31
2020-12-31	$1,188,504	20,400	-50.4%	Shares	Sole	2021-02-01
2020-03-31	$3,076,374	41,150	—	Shares	Sole	2020-05-01
No filing history on record for this holder in this stock.